Coronary interventions Safety and performance of a resorbable magnesium scaffold under real-world conditions: 12-month outcomes of the first 400 patients enrolled in the BIOSOLVE-IV registry Verheye S, Wlodarczak A, Montorsi P, Bennett J, Torzewski J, Haude M, Vrolix M, Buck T, Aminian A, van der Schaaf R, Arrif Nuruddin A, Lee MKY January 22, 2019 | 10.4244/EIJ-D-18-01058
Interventions for stroke AMPLATZER versus Figulla occluder for transcatheter patent foramen ovale closure Trabattoni D, Gaspardone A, Sgueglia G, Fabbiocchi F, Gioffrè G, Montorsi P, Calligaris G, Iamele M, De Santis A, Bartorelli A April 20, 2017 | 10.4244/EIJ-D-15-00499
Use of the Venture™ wire control catheter to access complex coronary lesions: how to turn procedural failure into success Aranzulla T, Sangiorgi G, Bartorelli A, Cosgrave J, Corbett S, Fabbiocchi F, Montorsi P, Montorfano M, Trabattoni D, Colombo A August 20, 2008
New issue Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue (Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right)) December 6, 2019
JAA This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more December 3, 2019
Trials Book New update! Discover 17 new trials (The Trials book is supported by Biotronik) October 29, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019